Perspective Therapeutics, Inc. (CATX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-49.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.43M | $0 | $10.05M | $9.68M | $7.31M | $5.92M | $4.76M | — |
| Cost of Revenue | — | — | — | $6.18M | $4.93M | $4.56M | $4.27M | $4.08M | $3.92M | $4.64M |
| Gross Profit | — | — | $1.43M | $0 | $5.12M | $5.12M | $3.05M | $1.84M | $838.0K | $129.0K |
| Operating Income | -$113.56M | -$90.89M | -$40.94M | -$8.67M | -$3.45M | -$3.48M | -$5.25M | -$6.73M | -$6.31M | -$5.08M |
| Net Income | -$103.12M | -$79.28M | -$46.51M | -$10.76M | -$3.39M | -$3.45M | -$5.14M | -$6.70M | -$6.16M | -$4.71M |
| EPS (Diluted) | $-1.40 | $-1.23 | $-1.74 | $-0.08 | $-0.03 | $-0.05 | — | — | — | — |
| Total Assets | $266.97M | $341.10M | $97.89M | $58.09M | $70.42M | $8.70M | $9.42M | $7.46M | $12.27M | $18.10M |
| Total Liabilities | $59.94M | $50.43M | $22.71M | $3.45M | $3.01M | $2.98M | $1.74M | $2.42M | $1.67M | $1.70M |
| Shareholders' Equity | $207.03M | $290.67M | $75.18M | $54.64M | $67.41M | $5.72M | $7.68M | $5.03M | $10.60M | $16.40M |
| Cash & Equivalents | $30.63M | $61.58M | $9.24M | $20.99M | $63.83M | $2.39M | $5.33M | $2.60M | $5.93M | $10.14M |
| Operating Cash Flow | -$82.48M | -$18.29M | -$36.91M | -$10.40M | -$2.84M | -$3.64M | -$5.05M | -$5.71M | -$5.71M | -$3.88M |
| Capital Expenditures | $12.75M | $54.41M | $1.07M | $282.0K | $381.0K | $273.0K | $444.0K | $337.0K | $549.0K | $479.0K |
| Shares Outstanding | 74.34M | 70.67M | 28.18M | 142.11M | 141.92M | 68.90M | 67.39M | 56.33M | 55.02M | 55.01M |